Doximity IncDOCS
Price$28.50Intrinsic value$33.0416% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $33.04median of 6 methods · middle span $18-$37based on filings through 30 Jun 2026
Market Price $28.50Price as of 1 Oct 2026
Margin of Safety +15.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -2.1% (near-term consensus, capped) · years 2–5: 8.5%/yr (balance of the path).6.3% per year
Years 6–10: glide to demonstrated growth own history 36.8%, capped at 20%
Per-year rates
Yr 68.1%Yr 77.6%Yr 87.2%Yr 96.7%Yr 106.3%
8.5% → 6.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 116.0%Yr 125.6%Yr 135.3%Yr 145.0%Yr 154.7%Yr 164.3%Yr 174.0%Yr 183.7%Yr 193.3%Yr 203.0%
6.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/6y) (limited history)36.8%
Discount rate (cost of equity) 10.1%
Volatility vs market (adjusted beta)1.14

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetDoximity IncDOCSHealth Care
Valuation
P/E33.9×
P/S7.2×
P/B5.5×
EV / Revenue6.8×
EV / EBITDA13.1×
Profitability
Gross margin89.1%
Operating margin33.3%
Net margin25.5%
FCF margin46.7%
Returns
ROE18.2%
ROA15.4%
ROIC26.0%
Growth
Revenue growth (YoY)14.9%
5-yr fwd EPS growth6.3%
Financial strength
Debt / Equity0.00×
Current ratio6.08×
Altman Z-Score18.8
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.